1,2-Methylenedioxy-8-(2-m-trifluoromethoxyphenyl-2-oxoethoxy)-9-methoxycycloberberine bromide

ID: ALA4174048

Chembl Id: CHEMBL4174048

PubChem CID: 145950176

Max Phase: Preclinical

Molecular Formula: C30H21BrF3NO6

Molecular Weight: 548.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c[n+]3c4c2ccc2c5c(cc(c24)CC3)OCO5)c1OCC(=O)c1cccc(OC(F)(F)F)c1.[Br-]

Standard InChI:  InChI=1S/C30H21F3NO6.BrH/c1-36-24-8-7-19-20-5-6-21-26-17(12-25-28(21)39-15-38-25)9-10-34(27(20)26)13-22(19)29(24)37-14-23(35)16-3-2-4-18(11-16)40-30(31,32)33;/h2-8,11-13H,9-10,14-15H2,1H3;1H/q+1;/p-1

Standard InChI Key:  OJOOHZDIIYQUOU-UHFFFAOYSA-M

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus saprophyticus (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus hominis (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 548.49Molecular Weight (Monoisotopic): 548.1315AlogP: 5.89#Rotatable Bonds: 6
Polar Surface Area: 67.10Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 1.82CX LogD: 1.82
Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.15Np Likeness Score: 0.35

References

1. Fan T, Hu X, Tang S, Liu X, Wang Y, Deng H, You X, Jiang J, Li Y, Song D..  (2018)  Discovery and Development of 8-Substituted Cycloberberine Derivatives as Novel Antibacterial Agents against MRSA.,  (5): [PMID:29795764] [10.1021/acsmedchemlett.8b00094]

Source